I’m honored to be invited to present the 16th Annual Mates David and Hinna Stahl Memorial Lecture at the Robert Wood Johnson Medical School, University of Medicine & Dentistry of New Jersey tomorrow (April 23).
My topic: “Addressing the Ethical Morass at the Intersection of Media, Medicine and Public Health.”
(Addendum on April 25: now that the talk has been given, I’ve posted my slides.)
It’s a coincidence that Dr. Jon LaPook of CBS News just recently told me that he had delivered The 45th Annual Fred T. Foard Jr. Memorial Lecture at the University of North Carolina Gillings School of Global Public Health. And his title was, “Public health at the intersection of medicine and the media.”
No, Jon, I did not copy you. My title was submitted a long time ago and our content doesn’t overlap. The themes are somewhat similar. But no direct overlap. But thanks for the mention in your talk – which begins about 19 minutes deep on this clip.
—————————–
Follow us on Facebook, and on Twitter:
Opinions on other issues in news, journals, PR, advertising, marketing
Puleeeeease... this 'game changer' weight loss drug causes more nausea and vomiting than a placebo. Some game, some change. My friend Gary would spank you for using the eighth word medical reporters should never, ever use. @garyschwitzer @thackerpd
https://www.healthnewsreview.org/toolkit/just-journalists-writing-tips-case-studies/7-words-and-more-you-shouldnt-use-in-medical-news/ https://twitter.com/OttawaCitizen/status/1361426796126830597
A scary @statnews Op-Ed warns that govt attempts to rein in Pharma may cut off access to "life-changing" drugs.
It takes @garyschwitzer to let us know: the author spent 10 years as Pfizer's public-policy chief. https://twitter.com/garyschwitzer/status/1360325022578053123
.@TranspariMED criticizes STAT op-ed for not disclosing pharma funding of author’s institute - similar to criticism we’ve made of STAT op-eds in the past. @transparify @ThinkTankWatch @icer_review https://www.healthnewsreview.org/2021/02/transparency-watchdog-criticizes-stats-non-disclosure-on-pro-pharma-op-ed/
Comments
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Marilyn Friedes
April 24, 2013 at 12:01 pmThank you for an enlightening talk yesterday in the Stahl Bioethics Lecture, bringing up issues that we tend to address superficially. We are always reassured by exuberantly optimistic media announcements of medical breakthroughs, ready to accept them without asking the pertinent questions you posed. I’m sending the link to your organization’s web site to my son-in-law who is working on his doctorate in statistics (biostatistics) at Tel Aviv University. Concerned about the ethics of medical information, he knows there is more to research than “lies, damned lies, and statistics”.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like